在临床实践中针对复发性/逆转性多发性骨髓瘤进行基于抗CD38的治疗的共识指南和建议:来自泛太平洋多发性骨髓瘤工作组
Wenming Chen1, Zhen Cai2, Chor Sang Chim3
1Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijingk, China.
Clinical hematology international
|August 11, 2025
概括
抗CD38单克隆抗体 (mAbs) 对复发性/耐药性多发性骨髓瘤 (RRMM) 是至关重要的. 这种共识为优化它们的使用提供了指导,包括管理毒性和重新治疗策略,以获得更好的患者结果.
科学领域:
- 血液学 血液学 血液学
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
背景情况:
- 反CD38单克隆抗体 (mAbs) 是治疗复发性/耐药性多发性骨髓瘤 (RRMM) 的组成部分.
- 最佳使用需要专家的共识,特别是对于不同的患者群体和不断变化的治疗环境.
研究的目的:
- 提供基于证据的指导,关于在RRMM中最佳使用抗CD38mAbs.
- 解决方案选择,特殊患者群体和毒性管理问题.
主要方法:
- 专家共识的发展.
- 在RRMM中对抗CD38 mAb的疗效和安全性的证据审查.
- 讨论患者分层和重新治疗策略.
主要成果:
- 抗CD38 mAb疗法在各种RRMM人群中显示出有效性,包括高危子组.
- 通过抗CD38 mAbs进行重新挑战,在洗期后是可行的,可能会恢复有效性.
- 这些药物在老年/脆弱患者和与新兴免疫疗法结合使用中非常有价值.
结论:
- 这种共识为RRMM中个性化抗CD38 mAb治疗提供了一个框架.
- 需要进一步的研究来优化抗CD38mAbs在现代RRMM治疗中的整合.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.9K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
